小儿输尿管镜钬激光内切开术治疗男性尿道狭窄

目的探讨小儿输尿管镜钬激光内切开术治疗男性尿道狭窄的安全性及临床疗效。 方法回顾性分析2014年8月至2017年4月我院42例行经尿道小儿输尿管镜钬激光内切开术治疗的男性尿道狭窄患者病历资料,患者年龄23～72岁,平均43岁,其中膜部尿道狭窄18例,前列腺部尿道狭窄5例,前尿道狭窄19例;狭窄段长度：0.3～2.5 cm,平均（1.4±0.3）cm,其中2例狭窄段长度2.0～2.5 cm;38例术前行自由尿流率检查,最大尿流率（Qmax）2.5～7.8 ml/s,平均（4.5±1.2）ml/s;术后留置尿管4～6周,拔除尿管后常规行尿道扩张3～4次,每次间隔1周,定期复查尿流率。 结果42例患者均顺利完成手术,手术时间30～70 min,平均（48±9）min,出血量少,无尿外渗、穿孔、感染等并发症,拔除尿管后排尿通畅。随访6～12个月,39例患者排尿通畅,最大尿流率明显改善,为12.6～22.5 ml/s,平均（16.3±3.7）ml/s,3例术后3个月尿线变细、尿流率下降行尿道扩张3～4次后排尿正常。 结论经尿道小儿输尿管镜钬激光内切开术治疗男性尿道狭窄安全、创伤小、并发症少,近期疗效满意。     

唇黏膜补片修复前尿道狭窄的疗效观察

目的 探讨应用唇黏膜补片尿道成形术治疗复杂性前尿道狭窄的有效性。方法：2004年3月～2008年9月应用自体下唇黏膜补片行尿道成形术治疗复杂性前尿道狭窄27例。尿道狭窄长度为2．0～7．0cm,平均长度3．9cm。结果：术后随访5～30个月,平均14．1个月。排尿通畅22例（81．5％）,最大尿流率16．9～40．2ml／s,平均23．6ml／s;再次狭窄5例（18．5％）,其中近端吻合口狭窄2例,远端吻合口狭窄2例,分别予以尿道内切开及扩张后,最大尿流率保持在15ml／s以上;1例行黏膜管状尿道成形术患者出现管腔缩窄,予以再次行口腔颊黏膜替代后排尿通畅。下唇取材部位黏膜均愈合良好,1例患者出现口周麻木并持续6个月。结论：下唇黏膜取材方便,取材后供体部位并发症少,适于用作尿道狭窄成形术的替代物。     

腔镜下钬激光内切开加定期尿道扩张治疗男性尿道狭窄及闭锁

目的探讨腔镜下钬激光内切开治疗男性尿道狭窄及闭锁的效果及安全性。方法我院2007年4月～2009年11月收治男性尿道狭窄或闭锁病人17例,狭窄段长0.5～3.0cm,平均1.4cm,采用腔镜下钬激光狭窄段内切开治疗。术后留置尿管2～4周。拔除尿管后根据随访排尿状况定期作尿道扩张。结果 17例病例均取得手术成功,手术时间30～90min,平均40min,术后排尿显著改善,最大尿流率(Qmax)由术前平均6.5(2.8～11.5)ml/s提高到术后20.4(16.6～25.3)ml/s,无尿失禁、阳痿、尿瘘并发症。术后随访3～18个月,均排尿良好,无再狭窄发生,B超检查剩余尿<20ml。结论腔镜下钬激光内切开加定期尿道扩张治疗男性尿道狭窄及闭锁安全有效,近期治疗效果良好,手术创伤小,并发症少,值得推广应用。     

舌黏膜补片治疗复杂性尿道狭窄的疗效观察

目的：探讨使用舌黏膜补片尿道成形治疗复杂性尿道狭窄的有效性。方法：2006年12月～2009年1月应用舌黏膜补片法治疗复杂性前尿道狭窄患者36例。结果：术后随访3～25个月，平均13．6个月。2例术后出现尿瘘，经再次手术修补后好转；另2例术后出现尿道狭窄，经尿道扩张后治愈。余者术后排尿通畅，平均最大尿流率达23．8ml／s。结论：舌黏膜具有取材方便、取材部位并发症少等优点，是一种治疗前尿道狭窄较好的替代物。     

良性前列腺增生术后复杂性后尿道狭窄的绿激光治疗

目的探讨腔内绿激光治疗良性前列腺增生术后复杂性后尿道狭窄的疗效。方法采用绿激光治疗良性前列腺增生术后复杂性后尿道狭窄患者20例，其中伴有假道者12例、伴2处以上狭窄者5例、合并尿道闭锁者5例；行经尿道瘢痕汽化切除，术后留置导尿管1～2周。结果20例患者手术均一次成功，手术时间30～65min，平均39min。随访2～10个月，18例一次治愈，排尿通畅，最大尿流率（Qmax）均〉15ml／s；1例拔除尿管后2周尿线变细，Qmax〈9ml／s，行定期尿道扩张6个月后治愈，Qmax〉15ml／s；轻度尿失禁1例。结论经尿道绿激光汽化治疗良性前列腺增生术后复杂性后尿道狭窄安争有效，手术操作简便，并发症少。     

经尿道钬激光治疗男性尿道狭窄

目的:探讨经尿道钬激光治疗男性尿道狭窄的方法、安全性和疗效。方法:对38例男性尿道狭窄患者行经尿道狭窄段疤痕钬激光切除(功率10~45W),狭窄段长度:<1.0cm者18例,1.0~1.5cm者9例,>1.5cm者7例,完全闭锁者4例,并发膀胱结石者6例。平均最大尿流率为(5.6±2.3)ml/s。结果:36例手术成功,无大出血、尿外渗、直肠损伤等并发症发生,术后平均最大尿流率为(17.5±3.4)ml/s,2例中转开放手术,32例获随访3~18个月,其中4例行定期尿道扩张,2例以钬激光行二次手术后治愈。结论:经尿道钬激光治疗男性尿道狭窄安全、有效、创伤小、可重复治疗。     

尿道内钬激光切开术治疗尿道狭窄的疗效观察

目的 探讨尿道内钬激光切开术治疗尿道狭窄的可行性.方法在直视下应用尿道镜对37例尿道狭窄患者施行尿道内钬激光切开术治疗.结果 35例手术成功,2例中转改开放手术.术后无大出血、尿外渗、直肠损伤等并发症发生,平均最大尿流率为(16～23.5)ml/s,术后随访6～12个月无尿道再狭窄发生.结论尿道内钬激光切开术是治疗尿道狭窄安全,有效的方法.     

Foley管牵引固定尿道拖入术治疗外伤性后尿道狭窄

目的　探讨Foley管作为牵引固定装置行尿道拖入术治疗外伤性后尿道狭窄或闭锁的方法。　方法　采用此方法治疗外伤性后尿道狭窄或闭锁患者 2 3例 ,对其临床资料进行总结。　结果　随访 6～ 12个月 ,14例排尿通畅 ,无需尿道扩张 ;7例术后近期需行尿道扩张 ;2例失败 ,其中 1例为狭窄段较长、术后尿道张力大所致 ,1例由伤口感染引起。 18例术后尿流率检查 :最大尿流率 15～2 3ml/s,平均 19ml/s;平均尿流率 10～ 13ml/s,平均 12ml/s。　结论　该手术方法操作简单、损伤小、并发症少、效果满意 ,临床应用价值较高     

KTP／532激光在治疗后尿道狭窄中的应用

目的探讨经尿道KTP／532激光治疗后尿道狭窄的临床效果。方法2005年3月～2008年6月,采用KTP／532激光汽化尿道瘢痕组织治疗后尿道狭窄患者39例。结果39例均一次手术成功。手术时间15～35min,平均28min;术后1～2d拔除导尿管．35例排尿通畅,最大尿流率（Qmax）〉15mL／s;4例排尿不畅,Qmax〈8mL／s,尿动力学检查显示与膀胱逼尿肌功能减遐有关。术后1个月,平均最大尿流率由术前的（5．6±2．1）mL／s升至（16．7±3．6）mL／s。36例获得随访3～18个月,3铡术后1个月发生尿流变细,经定期行尿道扩张后排尿通畅。结论经尿道KTP／532激光汽化术治疗后尿道狭窄安全有效,手术操作简单,术后恢复快,并发症少。     

男性长段尿道狭窄的经尿道腔内治疗分析(附12例报告)

目的:探索经尿道腔内治疗男性长段尿道狭窄的要点及临床疗效。方法:回顾性分析12例男性长段尿道狭窄患者的临床资料、治疗方法及长期随访结果。结果:12例患者尿道狭窄长度3~9cm,均一期成功进行经尿道尿道狭窄内切开术(7例使用钬激光,5例使用2μm激光),术后规律进行尿道扩张。随访时间6~72个月。所有患者均完成术后前6个月的规律尿道扩张,排尿持续通畅,术后6个月时尿道造影示狭窄段尿道管腔通畅、光滑,最大尿流率11~23ml/s,与手术前(2~8ml/s)相比差异有统计学意义(P0.01)。9例随访超过2年患者中,7例坚持完成2年规律的尿道扩张,排尿持续通畅,痊愈;2例未坚持后续尿道扩张,均逐渐出现排尿不畅情况,1例及时恢复尿道扩张后痊愈,1例再次行经尿道内切开术并规律尿道扩张后痊愈。结论:经尿道尿道狭窄内切开术配合术后规律尿道扩张是治疗男性长段尿道狭窄的有效方法之一。     

Vasopressor hormone response following mesenteric traction during major abdominal surgery

Background : We investigated the vasopressor hormone response following mesenteric traction (MT) with hypotension due to prostacyclin (PGI₂) release in patients undergoing abdominal surgery with a combined general and epidural anesthesia. Methods : In a prospective, randomized, placebo-controlled study we administered 400 mg ibuprofen (i.v.) in 42 patients scheduled for abdominal surgery. General anesthesia was combined with epidural anesthesia (T4-L1). Before as well as 5, 15, 30, 45, and 90 min after MT we recorded plasma osmolality, hemodynamics and measured 6-keto-PGFlα (stabile metabolite of PGI₂), TXB₂ (stabile metabolite of thromboxane A₂) active renin, and arginine vasopressin (AVP) plasma concentrations by radioimmunoassay. Catecholamine levels were assessed by high-pressure liquid chromatography (HPLC) with electrochemical detection. Results : Following MT, arterial hypotension occurred along with a substantial PGI₂ release. This was completely abolished by ibuprofen administration. Although plasma levels of 6-keto-PGF_1α (1133 (708) vs. 60 (3) ng/L, median (median absolute deviation), P=0.0001, placebo vs. ibuprofen) remained significantly elevated, blood pressure was restored within 30 min after MT in the placebo group. At the same point in time plasma concentrations of TXB² (164 (87) vs. 58 (1) ng/L, P=0.0001), epinephrine (46 (33) vs. 14 (6) ng/L, P=0.001), AVP (41 ± (18) vs. 12 (7) ng/L, P=0.0004), and active renin (27 (12) vs. 12 (4) ng/L, P = 0.001) were significantly higher in placebo-treated patients. Conclusion : Under combined general and epidural anesthesia arterial hypotension following MT due to endogenous PGI₂ release is associated with enhanced release of AVP, active renin, epinephrine and thromboxane A₂, presumably contributing to hemodynamic stability within 30 min after MT.     

A Teaspoon Pump for Pumping Blood with High Hydraulic Efficiency and Low Hemolysis Potential

Abstract: Virtually all blood pumps contain some kind of rubbing, sliding, closely moving machinery surfaces that are exposed to the blood being pumped. These valves, internal bearings, magnetic bearing position sensors, and shaft seals cause most of the problems with blood pumps. The original teaspoon pump design prevented the rubbing, sliding machinery surfaces from contacting the blood. However, the hydraulic efficiency was low because the blood was able to "slip around" the rotating impeller so that the blood itself never rotated fast enough to develop adequate pressure. An improved teaspoon blood pump has been designed and tested and has shown acceptable hydraulic performance and low hemolysis potential. The new pump uses a nonrotating "swinging" hose as the pump impeller. The fluid enters the pump through the center of the swinging hose; therefore, there can be no fluid slip between the revolving blood and the revolving impeller. The new pump uses an impeller that is comparable to a flexible garden hose. If the free end of the hose were swung around in a circle like half of a jump rope, the fluid inside the hose would rotate and develop pressure even though the hose impeller itself did not "rotate"; therefore, no rotating shaft seal or internal bearings are required.     

A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits

Background: Halothane inhibits in vitro and in vivo activity of cytochrome P-450 (CYP) 2E1. There are several fluorinated volatile anaesthetics besides halothane, and most of them are defluorinated by CYP2E1. It is unclear whether other fluorinated anaesthetics inhibit the in vivo activity of CYP2E1.
Methods: We compared the inhibitory effects of therapeutic concentrations of four inhalational anaesthetics, halothane, enflurane, isoflurane, and sevoflurane, on chlorzoxazone metabolism in rabbits receiving artificial ventilation.
Results: All four inhalational anaesthetics decreased arterial blood pressure and increased plasma chlorzoxazone concentration. However, no significant differences in the plasma chlorzoxazone concentration were found between the four anaesthetics. The estimated chlorzoxazone clearance increased after beginning inhalation with all four agents, but no significant difference in clearance was noted between agents.
Conclusions: At therapeutic concentrations, the in vivo inhibitory effect on chlorzoxazone metabolism was similar for all four inhalational anaesthetics examined, even though their chemical characteristics and extent of hepatic metabolism differ considerably.     

Microspheres Based Detoxification System: A New Method in Convective Blood Purification

Abstract: A variety of protein-bound or hydrophobic substances, accumulating as a result of pathologic conditions such as exogenous or endogenous intoxications, are removed poorly by conventional detoxification methods because of low accessibility (hemodialysis), insufficient adsorption capabilities (hemosorption), low efficiency (peritoneal dialysis), or economic limitations (high-volume plasmapheresis). Combining advantages of existing methods with microspheric technology, a module-based system was designed. Major operating parameters of the latter can be modified to allow for adjustment to individual clinical situations. An extracorporeal blood circuit including a plasmafilter is combined with a secondary high-velocity plasma circuit driven by a centrifugal pump. Different microspheric adsorbers can be combined in one circuit or applied in sequence. Thus, a prolonged treatment can be tailored using specially designed selective adsorber materials. Comparing this system with existing methods (high-flux hemodialysis, molecular adsorbent recycling system), results from our in vitro studies and animal experiments demonstrate the superior efficiency of substance removal.     

Tissue perfusion in relation to cardiac output during continuous positive-pressure ventilation and administration of propranolol or verapamil

Background : Our objective was to determine whether administration of propranolol or verapamil modifies the hemodynamic adaptation to continuous positive-pressure ventilation (CPPV), in particular the regional distribution of cardiac output (CO).
Methods : General hemodynamics and regional blood flows assessed by microsphere technique (15 (μm) were recorded in 16 anesthetized pigs during spontaneous breathing (SB) and CPPV with 8 cm H₂O end-expiratory pressure (CPPV8) before and after intravenous administration of propranolol (0.3 mg · kg⁻¹ followed by 0.15 mg · kg⁻¹ · h⁻¹, n=8) or verapamil (0.1 mg · kg⁻¹ followed by 0.3 mg · kg⁻¹ · h⁻¹, n=8).
Results : CPPV8 depressed CO by 25% without shifts in its relative distribution with the exception of a noteworthy increase in adrenal perfusion. Propranolol increased arterial blood pressure, and due to a fall in heart rate, CO dropped by 25%. The kidneys and, to a lesser extent, the splanchic region and central nervous system received increased fractions of the remaining CO at the expense of skeletal muscle flow. Similar patterns were seen during SB and CPPV8 such that the combination of propranolol and CPPV8 depressed CO by 50%. The circulatory effects of verapamil were less evident but myocardial perfusion tended to increase.
Conclusions : The combination of propranolol or verapamil with CPPV does not result in any specific hemodynamic interaction in anesthetized pigs, except that the combined effect of propranolol and CPPV may severely reduce CO.     

Bariatric Surgery in Some "Central and East-European (former Eastern bloc)"Countries - Current Status and Prediction for the Next Millennium

Background: Obesity is increasing globallly, including in the formerly "Eastern Bloc" countries. Methods: A survey was made of obesity and bariatric surgery. Results: In the 8 East and Central European countries studied, with total population 300 million, roughly 43% of the population was overweight (BMI 25-30), 23% obese (BMI > 30), with about 15 million people morbidly obese (BMI > 40). From 0-10 morbidly obese individuals/100,000/year undergo bariatric surgery. Conclusion: Most countries were found to provide inadequate treatment for obesity.The majority of the morbidly obese are not treated effectively. However, health-care awareness of obesity and bariatric surgeons are slowly increasing.     

Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts

Background : Inhibitory effects of volatile anaesthetics on platelet aggregation have been demonstrated in several studies. However, the influence of volatile anaesthetics on intracoronary platelet adhesion has not been elucidated so far.
Methods : Isolated hearts of guinea pigs were perfused with buffer in the absence or presence of volatile anaesthetics (0.5 and 1 MAC) at constant coronary flow rates of 5 ml/min for 25 min, then 1 ml/min for 30 min and again 5 ml/min for 10 min. Before, during and after low-flow perfusion, a bolus of human platelets was applied into the coronary system. To simulate thrombogenic conditions, 0.3 U/ml human thrombin was infused during low-flow perfusion and reperfusion. The number of platelets sequestered to the endothelium was calculated from the difference between coronary in- and output of platelets. The myocardial production of lactate and consumption of pyruvate and coronary perfusion pressure were also determined.
Results : At a flow rate of 5 ml/min only about 3% of the applied platelets did not emerge from the coronary system, in any group. In contrast, 13.1±1.2% (mean±SEM) of infused platelets became adherent in low-flow perfusion in the control group without anaesthetic. The adherence was reduced with each 1 MAC isoflurane (to 6.2±1.2%), sevoflurane (to 4.4±0.9%) or halothane (to 3.2±1.5%) (each P <0.05 vs. control). Volatile anaesthetic, 0.5 MAC, did not inhibit platelet adhesion to a statistically significant extent in any case. Perfusion pressure and metabolic parameters were not statistically different between the control and the hearts exposed to anaesthetics.
Conclusion : Volatile anaesthetics in a concentration of 1 MAC can reduce the adhesion of platelets in the coronary system under reduced flow conditions. This action does not arise from vasodilation or inhibition of ischaemic stress.     

Synergistic interaction between the effects of propofol and midazolam with fentanyl on phrenic nerve activity in rabbits

Background: It has been shown that the depressive effects of both propofol and midazolam on consciousness are synergistic with opioids, but the nature of their interactions on other physiological systems, e. g. respiration, has not been fully investigated. The present study examined the effect of propofol and midazolam alone and in combination with fentanyl on phrenic nerve activity (PNA) and whether such interactions are additive or synergistic. Methods: PNA was recorded in 27 anaesthetised and artificially ventilated rabbits. In three groups, propofol, fentanyl and midazolam were administered intravenously in incremental doses to construct dose-response curves for the depressant effects of each one on PNA. In another two groups, the effect of pretreatment with either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. on the effects of propofol and fentanyl respectively on PNA were studied. Results: Propofol and fentanyl caused a dose-dependent depression of PNA with complete abolition at the highest total doses of 16 mg · kg^?1 i. v. and 32 μg · kg^?1 i. v., respectively. In contrast, midazolam in incremental doses to a total of 0.8 mg · kg^?1 reduced mean PNA by 63%, but approximately 12% of PNA remained at a total dose as high as 6.4 mg · kg^?1. The mean ED₅₀s, calculated from dose-response curves, were 5.4 mg · kg^?1, 3.9 μg · kg^?1 and 0.4 mg · kg^?1 for propofol, fentanyl and midazolam, respectively. Initial doses of either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. acted synergistically with subsequent doses of either propofol or fentanyl to abolish PNA at total doses of 8 mg · kg^?1 and 8 μg · kg^?1, respectively. Conclusion: Fentanyl has a synergistic interaction with both propofol and midazolam on PNA and hence potentially on respiration.     

Influence of dopexamine hydrochloride on haemodynamics and regulators of circulation in patients undergoing major abdominal surgery

Background: Catecholaminergic support is often used to improve haemodynamics in patients undergoing major abdominal surgery. Dopexamine is a synthetic vasoactive catecholamine with beneficial microcirculatory properties. Methods: The influence of perioperative administration of dopexamine on cardiorespiratory data and important regulators of macro- and microcirculation were studied in 30 patients undergoing Whipple pancreaticduodenectomy. The patients received randomized and blinded either 2 μg · kg^?1 · min^?1 of dopexamine (n=15) or placebo (n=15, control group). The infusion was started after induction of anaesthesia and continued until the morning of the first postoperative day. Endothelin-1 (ET-1), vasopressin, atrial natriuretic peptide (ANP), and catecholamine plasma levels were measured from arterial blood samples. Measurements were carried out after induction of anaesthesia, 2 h after onset of surgery, at the end of surgery, 2 h after surgery, and on the morning of the first postoperative day. Results: Cardiac index (CI) increased significantly in the dopexamine group (from 2.61±0.41 to 4.57±0.78 1 · min^?1 · m^?2) and remained elevated until the morning of the first postoperative day. Oxygen delivery index (DO₂I) and oxygen consumption index (VO₂I) were also significantly increased in the dopexamine group (DO₂I: from 416±91 to 717±110 ml/m² · m²; VO₂I: from 98±25 to 157±22 ml/m² · m²), being significantly higher than in the control group. pHi remained stable only in the dopexamine patients, indicating adequate splanchnic perfusion. Vasopressive regulators of circulation increased significantly only in the untreated control patients (vasopressin: from 4.37±1.1 to 35.9±12.1 pg/ml; ET-1: from 2.88±0.91 to 6.91±1.20 pg/ml). Conclusion: Patients undergoing major abdominal surgery may profit from prophylactic perioperative administration of dopexamine hydrochloride in the form of improved haemodynamics and oxygenation as well as beneficial influence on important regulators of organ blood flow.     

Systemic analgesia adapted to the children's condition

A concept of balanced analgesia using nonsteroidal anti-inflammatory drugs (NSAIDs), paracetamol (acetaminophen), opioids, and corticosteroids can also be used in patients with pre-existing illnesses. NSAIDs are the most effective treatment for acute pain of moderate intensity in children; however, these drugs should be avoided in patients at increased risk for serious side effects, e.g. patients with renal impairment, bleeding tendency, or extreme prematurity. NSAIDs can be given with minimal risks to the younger child with mild to moderate asthma, and, in these patients, the use of steroids can be encouraged; in addition to their antiemetic and analgesic action, a beneficial effect on asthma symptoms can be expected. In the non-intubated child with cerebral trauma, exaggerated sedation caused by opioids and increased bleeding tendency caused by NSAIDs must be avoided. In neonates and small infants, the oral administration of sucrose or glucose is helpful to minimize pain reaction during short uncomfortable interventions.